SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The sales is pegged at Rs. 1751.80 millions for the September 2025 quarter. The mentioned figure indicates decline with the sales recorded at Rs. 2079.30 millions during the year-ago period.The Net Profit of the company registered a slight decline of -2.98% to Rs. 1025.90  millions from Rs. 1057.40 millions.Operating Profit reported a sharp decline to 1350.70 millions from 1411.70 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202509 202409 % Var 202509 202409 % Var 202503 202403 % Var
Sales 1751.80 2079.30 -15.75 3577.50 3935.70 -9.10 7524.10 6250.90 20.37
Other Income 592.20 430.10 37.69 912.50 645.10 41.45 1345.90 1058.40 27.16
PBIDT 1350.70 1411.70 -4.32 2537.10 2440.50 3.96 4665.60 3929.20 18.74
Interest 0.50 0.20 150.00 0.90 0.40 125.00 1.20 1.00 20.00
PBDT 1350.20 1411.50 -4.34 2536.20 2440.10 3.94 4664.40 3928.20 18.74
Depreciation 60.20 64.90 -7.24 121.60 126.70 -4.03 247.70 270.80 -8.53
PBT 1290.00 1346.60 -4.20 2414.60 2313.40 4.37 4416.70 3657.40 20.76
TAX 264.10 289.20 -8.68 529.80 530.60 -0.15 1021.80 820.30 24.56
Deferred Tax -3.60 -2.30 56.52 -7.00 -6.60 6.06 -7.20 -40.90 -82.40
PAT 1025.90 1057.40 -2.98 1884.80 1782.80 5.72 3394.90 2837.10 19.66
Equity 152.00 152.00 0.00 152.00 152.00 0.00 152.00 151.90 0.07
PBIDTM(%) 77.10 67.89 13.57 70.92 62.01 14.37 62.01 62.86 -1.35

Caplin Point Lab Share Price

1754.25 -18.25 (-1.03%)
20-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1668.00
Dr. Reddys Lab 1232.25
Cipla 1228.90
Zydus Lifesciences 936.35
Lupin 2328.60
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×